Frequencies for measure_dates dataset : by Jean Roth , jroth@nber.org , 15 Nov 2016 Frequencies for measure_name variable in measure_dates dataset : Measure_Name | Freq. Percent Cum. ----------------------------------------+----------------------------------- Adjuvant Hormonal Therapy | 1 0.64 0.64 30-Day All-Cause Mortality Following .. | 1 0.64 1.28 30-Day All-Cause Unplanned Readmissio.. | 1 0.64 1.92 30-Day Hospital-Wide All-Cause Unplan.. | 1 0.64 2.56 30-Day Readmission Rate Following Ele.. | 1 0.64 3.21 ACS Participation data | 1 0.64 3.85 AHRQ_PSI_90_Score | 1 0.64 4.49 Abdomen CT - Use of Contrast Material | 1 0.64 5.13 Accidental puncture or laceration | 1 0.64 5.77 Acute Ischemic Stroke (STK) 30-Day Mo.. | 1 0.64 6.41 Acute Myocardial Infarction (AMI) 30-.. | 3 1.92 8.33 Acute Myocardial Infarction (AMI) 30-.. | 1 0.64 8.97 Acute Myocardial Infarction (AMI) 30-.. | 1 0.64 9.62 Adjuvant Chemotherapy Colon Cancer | 1 0.64 10.26 Admit Decision Time to ED Departure T.. | 1 0.64 10.90 Alcohol Use Screening | 1 0.64 11.54 Anticoagulation Therapy for Atrial Fi.. | 1 0.64 12.18 Antithrombotic Therapy By End of Hosp.. | 1 0.64 12.82 Aspirin at Arrival | 1 0.64 13.46 Assessed for Rehabilitation | 1 0.64 14.10 Assessment of Patient Experience of C.. | 1 0.64 14.74 CAUTI_Score | 1 0.64 15.38 CLABSI_Score | 1 0.64 16.03 Cardiac imaging for preoperative risk.. | 1 0.64 16.67 Catheter Associated Urinary Tract Inf.. | 2 1.28 17.95 Catheter Associated Urinary Tract Inf.. | 1 0.64 18.59 Catheter Associated Urinary Tract Inf.. | 1 0.64 19.23 Central Line Associated Bloodstream I.. | 2 1.28 20.51 Central Line Associated Bloodstream I.. | 1 0.64 21.15 Central Line Associated Bloodstream I.. | 1 0.64 21.79 Chronic Obstructive Pulmonary Disease.. | 1 0.64 22.44 Chronic Obstructive Pulmonary Disease.. | 2 1.28 23.72 Clostridium Difficile (C.Diff) | 1 0.64 24.36 Combination Chemotherapy Breast Cancer | 1 0.64 25.00 Combined SSI | 2 1.28 26.28 Complication Rate Following Elective .. | 1 0.64 26.92 Complication Rate Following Elective .. | 1 0.64 27.56 Complication/patient safety for selec.. | 3 1.92 29.49 Death among surgical inpatients with .. | 1 0.64 30.13 Discharged on Antithrombotic Therapy | 1 0.64 30.77 Discharged on Statin Medication | 1 0.64 31.41 Does your facility have the ability t.. | 1 0.64 32.05 Does/did your facility have the abili.. | 1 0.64 32.69 Domain_1_Score | 1 0.64 33.33 Domain_2_Score | 1 0.64 33.97 Elective Delivery | 1 0.64 34.62 Emergency Department Volume | 1 0.64 35.26 Evaluation of LVS Function | 1 0.64 35.90 Fibrinolytic Therapy Received Within .. | 1 0.64 36.54 Fibrinolytic Therapy Received Within .. | 2 1.28 37.82 Fibrinolytic Therapy Received within .. | 1 0.64 38.46 Follow-up after Hospitalization for M.. | 1 0.64 39.10 Follow-up after Hospitalization for M.. | 1 0.64 39.74 HCAHPS Linear Score for each measure | 1 0.64 40.38 HCAHPS Measures | 2 1.28 41.67 HCAHPS Summary Star Rating | 1 0.64 42.31 Head CT Scan Results for Acute Ischem.. | 1 0.64 42.95 Healthcare Personnel Influenza Vaccin.. | 1 0.64 43.59 Heart Failure (HF) 30-Day Readmissio.. | 1 0.64 44.23 Heart Failure (HF) 30-Day Mortality R.. | 3 1.92 46.15 Heart Failure (HF) 30-Day Readmissions | 1 0.64 46.79 Home Management Plan of Care (HMPC) D.. | 1 0.64 47.44 Hospital Acquired Potentially-Prevent.. | 1 0.64 48.08 Hospital Outpatient Volume Data on Se.. | 1 0.64 48.72 Hours of physical-restraint use | 1 0.64 49.36 Hours of seclusion | 1 0.64 50.00 Iatrogenic pneumothorax, adult | 1 0.64 50.64 Influenza Immunization | 3 1.92 52.56 Initial Antibiotic Selection for CAP .. | 3 1.92 54.49 Intensive Care Unit Venous Thromboemb.. | 1 0.64 55.13 MRI Lumbar Spine for Low Back Pain | 1 0.64 55.77 MRSA Bacteremia | 1 0.64 56.41 Mammography Follow-up Rates | 1 0.64 57.05 Median Time from ED Arrival to ED Dep.. | 1 0.64 57.69 Median Time from ED Arrival to ED Dep.. | 1 0.64 58.33 Median Time from ED Arrival to Provid.. | 1 0.64 58.97 Median Time to ECG | 1 0.64 59.62 Median Time to Fibrinolysis | 1 0.64 60.26 Median Time to Pain Management for Lo.. | 1 0.64 60.90 Median Time to Transfer to Another Fa.. | 1 0.64 61.54 Participation in a Systematic Clinica.. | 1 0.64 62.18 Participation in a Systematic Clinica.. | 1 0.64 62.82 Participation in a Systematic Databas.. | 1 0.64 63.46 Patient left without being seen | 1 0.64 64.10 Patient satisfaction survey results | 1 0.64 64.74 Patients discharged on multiple antip.. | 1 0.64 65.38 Patients discharged on multiple antip.. | 1 0.64 66.03 Pneumonia 30-Day Mortality Rate | 3 1.92 67.95 Pneumonia 30-Day Readmission Rate | 1 0.64 68.59 Pneumonia 30-Day Readmissions | 1 0.64 69.23 Post-Operative Pulmonary Embolism (PE.. | 1 0.64 69.87 Post-discharge continuing care plan c.. | 1 0.64 70.51 Post-discharge continuing care plan t.. | 1 0.64 71.15 Postoperative wound dehiscence | 1 0.64 71.79 Primary PCI Received Within 90 Minute.. | 1 0.64 72.44 Prophylactic Antibiotic Received With.. | 1 0.64 73.08 Prophylactic Antibiotic Selection for.. | 3 1.92 75.00 Prophylactic Antibiotics Discontinued.. | 3 1.92 76.92 Risk-Standardized Payment Associated .. | 1 0.64 77.56 Risk-Standardized Payment Associated .. | 1 0.64 78.21 Risk-Standardized Payment Associated .. | 1 0.64 78.85 SSI - Abdominal Hysterectomy | 3 1.92 80.77 SSI - Colon Surgery | 3 1.92 82.69 SSI_Score | 1 0.64 83.33 Safe Surgery Checklist Use | 2 1.28 84.62 Simultaneous use of brain Computed To.. | 1 0.64 85.26 Spending per Hospital Patient with Me.. | 3 1.92 87.18 Stroke (STK) 30-Day Readmission Rate | 1 0.64 87.82 Stroke Education | 1 0.64 88.46 Surgery Patients Who Received Appropr.. | 3 1.92 90.38 Surgery Patients on Beta-Blocker Ther.. | 3 1.92 92.31 Thorax CT - Use of Contrast Material | 1 0.64 92.95 Thrombolytic Therapy | 1 0.64 93.59 Total_HAC_Score | 1 0.64 94.23 Urinary Catheter Removed on Postoper.. | 3 1.92 96.15 Use of an Electronic Health Record | 1 0.64 96.79 Venous Thromboembolism (VTE) Prophyla.. | 1 0.64 97.44 Venous Thromboembolism Patients Recei.. | 1 0.64 98.08 Venous Thromboembolism Patients with .. | 1 0.64 98.72 Venous Thromboembolism Prophylaxis | 1 0.64 99.36 Venous Thromboembolism Warfarin Thera.. | 1 0.64 100.00 ----------------------------------------+----------------------------------- Total | 156 100.00 Frequencies for measure_id variable in measure_dates dataset : Measure ID | Freq. Percent Cum. ----------------------------------------+----------------------------------- ACS_REGISTRY | 1 0.64 0.64 AMI_7a | 1 0.64 1.28 AMI_7a_HVBP_Baseline | 1 0.64 1.92 AMI_7a_HVBP_Performance | 1 0.64 2.56 AMI_8a | 1 0.64 3.21 CAC_3 | 1 0.64 3.85 COMP_HIP_KNEE | 1 0.64 4.49 Combined_SSI_Measure_Score | 1 0.64 5.13 Combined_SSI_Measure_Score_HVBP_Perfo.. | 1 0.64 5.77 EDV | 1 0.64 6.41 ED_1b | 1 0.64 7.05 ED_2b | 1 0.64 7.69 FUH_30 | 1 0.64 8.33 FUH_7 | 1 0.64 8.97 HACRP_CAUTI | 1 0.64 9.62 HACRP_CLABSI | 1 0.64 10.26 HACRP_D1 | 1 0.64 10.90 HACRP_D2 | 1 0.64 11.54 HACRP_PSI90 | 1 0.64 12.18 HACRP_SSI | 1 0.64 12.82 HACRP_Total | 1 0.64 13.46 HAI_1 | 1 0.64 14.10 HAI_1_HVBP_Baseline | 1 0.64 14.74 HAI_1_HVBP_Performance | 1 0.64 15.38 HAI_1a | 1 0.64 16.03 HAI_2 | 1 0.64 16.67 HAI_2_HVBP_Baseline | 1 0.64 17.31 HAI_2_HVBP_Performance | 1 0.64 17.95 HAI_2a | 1 0.64 18.59 HAI_3 | 1 0.64 19.23 HAI_3_HVBP_Baseline | 1 0.64 19.87 HAI_3_HVBP_Performance | 1 0.64 20.51 HAI_4 | 1 0.64 21.15 HAI_4_HVBP_Baseline | 1 0.64 21.79 HAI_4_HVBP_Performance | 1 0.64 22.44 HAI_5 | 1 0.64 23.08 HAI_6 | 1 0.64 23.72 HBIPS_2 | 1 0.64 24.36 HBIPS_3 | 1 0.64 25.00 HBIPS_4 | 1 0.64 25.64 HBIPS_5 | 1 0.64 26.28 HBIPS_6 | 1 0.64 26.92 HBIPS_7 | 1 0.64 27.56 HCAHPS | 1 0.64 28.21 HCAHPS_HVBP_Baseline | 1 0.64 28.85 HCAHPS_HVBP_Performance | 1 0.64 29.49 HF_2 | 1 0.64 30.13 IMM_2 | 1 0.64 30.77 IMM_2_HVBP_Baseline | 1 0.64 31.41 IMM_2_HVBP_Performance | 1 0.64 32.05 IMM_3_OP_27 | 1 0.64 32.69 IPFQR_EHR | 1 0.64 33.33 IPFQR_PEoC | 1 0.64 33.97 Linear Score | 1 0.64 34.62 MORT_30_AMI | 1 0.64 35.26 MORT_30_AMI_HVBP_Baseline | 1 0.64 35.90 MORT_30_AMI_HVBP_Performance | 1 0.64 36.54 MORT_30_CABG | 1 0.64 37.18 MORT_30_COPD | 1 0.64 37.82 MORT_30_HF | 1 0.64 38.46 MORT_30_HF_HVBP_Baseline | 1 0.64 39.10 MORT_30_HF_HVBP_Performance | 1 0.64 39.74 MORT_30_PN | 1 0.64 40.38 MORT_30_PN_HVBP_Baseline | 1 0.64 41.03 MORT_30_PN_HVBP_Performance | 1 0.64 41.67 MORT_30_STK | 1 0.64 42.31 MSPB_1 | 1 0.64 42.95 MSPB_1_HVBP_Baseline | 1 0.64 43.59 MSPB_1_HVBP_Performance | 1 0.64 44.23 OP_1 | 1 0.64 44.87 OP_10 | 1 0.64 45.51 OP_11 | 1 0.64 46.15 OP_12 | 1 0.64 46.79 OP_13 | 1 0.64 47.44 OP_14 | 1 0.64 48.08 OP_17 | 1 0.64 48.72 OP_18b | 1 0.64 49.36 OP_2 | 1 0.64 50.00 OP_20 | 1 0.64 50.64 OP_21 | 1 0.64 51.28 OP_22 | 1 0.64 51.92 OP_23 | 1 0.64 52.56 OP_25 | 1 0.64 53.21 OP_26 | 1 0.64 53.85 OP_3b | 1 0.64 54.49 OP_4 | 1 0.64 55.13 OP_5 | 1 0.64 55.77 OP_8 | 1 0.64 56.41 OP_9 | 1 0.64 57.05 PAYM_30_AMI | 1 0.64 57.69 PAYM_30_HF | 1 0.64 58.33 PAYM_30_PN | 1 0.64 58.97 PCH_1 | 1 0.64 59.62 PCH_2 | 1 0.64 60.26 PCH_3 | 1 0.64 60.90 PC_01 | 1 0.64 61.54 PN_6 | 1 0.64 62.18 PN_6_HVBP_Baseline | 1 0.64 62.82 PN_6_HVBP_Performance | 1 0.64 63.46 PSI_12 | 1 0.64 64.10 PSI_14 | 1 0.64 64.74 PSI_15 | 1 0.64 65.38 PSI_4 | 1 0.64 66.03 PSI_6 | 1 0.64 66.67 PSI_90 | 1 0.64 67.31 PSI_90_HVBP_Baseline | 1 0.64 67.95 PSI_90_HVBP_Performance | 1 0.64 68.59 READM_30_AMI | 1 0.64 69.23 READM_30_AMI_HRRP | 1 0.64 69.87 READM_30_CABG | 1 0.64 70.51 READM_30_COPD | 1 0.64 71.15 READM_30_COPD_HRRP | 1 0.64 71.79 READM_30_HF | 1 0.64 72.44 READM_30_HF_HRRP | 1 0.64 73.08 READM_30_HIP_KNEE | 1 0.64 73.72 READM_30_HIP_KNEE_HRRP | 1 0.64 74.36 READM_30_HOSP_WIDE | 1 0.64 75.00 READM_30_PN | 1 0.64 75.64 READM_30_PN_HRRP | 1 0.64 76.28 READM_30_STK | 1 0.64 76.92 SCIP_Card_2 | 1 0.64 77.56 SCIP_Card_2_HVBP_Baseline | 1 0.64 78.21 SCIP_Card_2_HVBP_Performance | 1 0.64 78.85 SCIP_Inf_1 | 1 0.64 79.49 SCIP_Inf_2 | 1 0.64 80.13 SCIP_Inf_2_HVBP_Baseline | 1 0.64 80.77 SCIP_Inf_2_HVBP_Performance | 1 0.64 81.41 SCIP_Inf_3 | 1 0.64 82.05 SCIP_Inf_3_HVBP_Baseline | 1 0.64 82.69 SCIP_Inf_3_HVBP_Performance | 1 0.64 83.33 SCIP_Inf_9 | 1 0.64 83.97 SCIP_Inf_9_HVBP_Baseline | 1 0.64 84.62 SCIP_Inf_9_HVBP_Performance | 1 0.64 85.26 SCIP_VTE_2 | 1 0.64 85.90 SCIP_VTE_2_HVBP_Baseline | 1 0.64 86.54 SCIP_VTE_2_HVBP_Performance | 1 0.64 87.18 SM_5 | 1 0.64 87.82 SM_PART_CARD | 1 0.64 88.46 SM_PART_GEN_SURG | 1 0.64 89.10 SM_PART_NURSE | 1 0.64 89.74 STK_1 | 1 0.64 90.38 STK_10 | 1 0.64 91.03 STK_2 | 1 0.64 91.67 STK_3 | 1 0.64 92.31 STK_4 | 1 0.64 92.95 STK_5 | 1 0.64 93.59 STK_6 | 1 0.64 94.23 STK_8 | 1 0.64 94.87 SUB_1 | 1 0.64 95.51 Star Rating | 1 0.64 96.15 VTE_1 | 1 0.64 96.79 VTE_2 | 1 0.64 97.44 VTE_3 | 1 0.64 98.08 VTE_4 | 1 0.64 98.72 VTE_5 | 1 0.64 99.36 VTE_6 | 1 0.64 100.00 ----------------------------------------+----------------------------------- Total | 156 100.00 Frequencies for measure_start_quarter variable in measure_dates dataset : Measure_Sta | rt_Quarter | Freq. Percent Cum. ------------+----------------------------------- 1Q2012 | 15 9.62 9.62 1Q2013 | 10 6.41 16.03 1Q2014 | 31 19.87 35.90 1Q2015 | 2 1.28 37.18 2Q2011 | 1 0.64 37.82 2Q2014 | 1 0.64 38.46 3Q2011 | 21 13.46 51.92 3Q2012 | 9 5.77 57.69 3Q2013 | 10 6.41 64.10 3Q2014 | 46 29.49 93.59 4Q2010 | 4 2.56 96.15 4Q2012 | 4 2.56 98.72 4Q2014 | 2 1.28 100.00 ------------+----------------------------------- Total | 156 100.00 Frequencies for measure_start_date variable in measure_dates dataset : Measure_Start_Dat | e | Freq. Percent Cum. ------------------+----------------------------------- 01/01/12 00:00:00 | 15 9.62 9.62 01/01/13 00:00:00 | 10 6.41 16.03 01/01/14 00:00:00 | 31 19.87 35.90 01/01/15 00:00:00 | 2 1.28 37.18 04/01/11 00:00:00 | 1 0.64 37.82 04/01/14 00:00:00 | 1 0.64 38.46 07/01/11 00:00:00 | 21 13.46 51.92 07/01/12 00:00:00 | 9 5.77 57.69 07/01/13 00:00:00 | 10 6.41 64.10 07/01/14 00:00:00 | 46 29.49 93.59 10/01/10 00:00:00 | 3 1.92 95.51 10/01/12 00:00:00 | 3 1.92 97.44 10/01/14 00:00:00 | 2 1.28 98.72 10/15/10 00:00:00 | 1 0.64 99.36 10/15/12 00:00:00 | 1 0.64 100.00 ------------------+----------------------------------- Total | 156 100.00 Frequencies for measure_end_quarter variable in measure_dates dataset : Measure_End | _Quarter | Freq. Percent Cum. ------------+----------------------------------- 1Q2014 | 1 0.64 0.64 1Q2015 | 3 1.92 2.56 2Q2011 | 4 2.56 5.13 2Q2014 | 43 27.56 32.69 2Q2015 | 48 30.77 63.46 4Q2012 | 15 9.62 73.08 4Q2013 | 6 3.85 76.92 4Q2014 | 36 23.08 100.00 ------------+----------------------------------- Total | 156 100.00 Frequencies for measure_end_date variable in measure_dates dataset : Measure_End_Date | Freq. Percent Cum. ------------------+----------------------------------- 03/31/14 00:00:00 | 1 0.64 0.64 03/31/15 00:00:00 | 3 1.92 2.56 06/30/11 00:00:00 | 4 2.56 5.13 06/30/14 00:00:00 | 43 27.56 32.69 06/30/15 00:00:00 | 48 30.77 63.46 12/31/12 00:00:00 | 15 9.62 73.08 12/31/13 00:00:00 | 6 3.85 76.92 12/31/14 00:00:00 | 36 23.08 100.00 ------------------+----------------------------------- Total | 156 100.00 Frequencies for msr_cd variable in measure_dates dataset : Measure ID | Freq. Percent Cum. ----------------------------------------+----------------------------------- ACS_REGISTRY | 1 0.64 0.64 AMI_7a | 1 0.64 1.28 AMI_7a_HVBP_Baseline | 1 0.64 1.92 AMI_7a_HVBP_Performance | 1 0.64 2.56 AMI_8a | 1 0.64 3.21 CAC_3 | 1 0.64 3.85 COMP_HIP_KNEE | 1 0.64 4.49 Combined_SSI_Measure_Score | 1 0.64 5.13 Combined_SSI_Measure_Score_HVBP_Perfo.. | 1 0.64 5.77 EDV | 1 0.64 6.41 ED_1b | 1 0.64 7.05 ED_2b | 1 0.64 7.69 FUH_30 | 1 0.64 8.33 FUH_7 | 1 0.64 8.97 HACRP_CAUTI | 1 0.64 9.62 HACRP_CLABSI | 1 0.64 10.26 HACRP_D1 | 1 0.64 10.90 HACRP_D2 | 1 0.64 11.54 HACRP_PSI90 | 1 0.64 12.18 HACRP_SSI | 1 0.64 12.82 HACRP_Total | 1 0.64 13.46 HAI_1 | 1 0.64 14.10 HAI_1_HVBP_Baseline | 1 0.64 14.74 HAI_1_HVBP_Performance | 1 0.64 15.38 HAI_1a | 1 0.64 16.03 HAI_2 | 1 0.64 16.67 HAI_2_HVBP_Baseline | 1 0.64 17.31 HAI_2_HVBP_Performance | 1 0.64 17.95 HAI_2a | 1 0.64 18.59 HAI_3 | 1 0.64 19.23 HAI_3_HVBP_Baseline | 1 0.64 19.87 HAI_3_HVBP_Performance | 1 0.64 20.51 HAI_4 | 1 0.64 21.15 HAI_4_HVBP_Baseline | 1 0.64 21.79 HAI_4_HVBP_Performance | 1 0.64 22.44 HAI_5 | 1 0.64 23.08 HAI_6 | 1 0.64 23.72 HBIPS_2 | 1 0.64 24.36 HBIPS_3 | 1 0.64 25.00 HBIPS_4 | 1 0.64 25.64 HBIPS_5 | 1 0.64 26.28 HBIPS_6 | 1 0.64 26.92 HBIPS_7 | 1 0.64 27.56 HCAHPS | 1 0.64 28.21 HCAHPS_HVBP_Baseline | 1 0.64 28.85 HCAHPS_HVBP_Performance | 1 0.64 29.49 HF_2 | 1 0.64 30.13 IMM_2 | 1 0.64 30.77 IMM_2_HVBP_Baseline | 1 0.64 31.41 IMM_2_HVBP_Performance | 1 0.64 32.05 IMM_3_OP_27 | 1 0.64 32.69 IPFQR_EHR | 1 0.64 33.33 IPFQR_PEoC | 1 0.64 33.97 Linear Score | 1 0.64 34.62 MORT_30_AMI | 1 0.64 35.26 MORT_30_AMI_HVBP_Baseline | 1 0.64 35.90 MORT_30_AMI_HVBP_Performance | 1 0.64 36.54 MORT_30_CABG | 1 0.64 37.18 MORT_30_COPD | 1 0.64 37.82 MORT_30_HF | 1 0.64 38.46 MORT_30_HF_HVBP_Baseline | 1 0.64 39.10 MORT_30_HF_HVBP_Performance | 1 0.64 39.74 MORT_30_PN | 1 0.64 40.38 MORT_30_PN_HVBP_Baseline | 1 0.64 41.03 MORT_30_PN_HVBP_Performance | 1 0.64 41.67 MORT_30_STK | 1 0.64 42.31 MSPB_1 | 1 0.64 42.95 MSPB_1_HVBP_Baseline | 1 0.64 43.59 MSPB_1_HVBP_Performance | 1 0.64 44.23 OP_1 | 1 0.64 44.87 OP_10 | 1 0.64 45.51 OP_11 | 1 0.64 46.15 OP_12 | 1 0.64 46.79 OP_13 | 1 0.64 47.44 OP_14 | 1 0.64 48.08 OP_17 | 1 0.64 48.72 OP_18b | 1 0.64 49.36 OP_2 | 1 0.64 50.00 OP_20 | 1 0.64 50.64 OP_21 | 1 0.64 51.28 OP_22 | 1 0.64 51.92 OP_23 | 1 0.64 52.56 OP_25 | 1 0.64 53.21 OP_26 | 1 0.64 53.85 OP_3b | 1 0.64 54.49 OP_4 | 1 0.64 55.13 OP_5 | 1 0.64 55.77 OP_8 | 1 0.64 56.41 OP_9 | 1 0.64 57.05 PAYM_30_AMI | 1 0.64 57.69 PAYM_30_HF | 1 0.64 58.33 PAYM_30_PN | 1 0.64 58.97 PCH_1 | 1 0.64 59.62 PCH_2 | 1 0.64 60.26 PCH_3 | 1 0.64 60.90 PC_01 | 1 0.64 61.54 PN_6 | 1 0.64 62.18 PN_6_HVBP_Baseline | 1 0.64 62.82 PN_6_HVBP_Performance | 1 0.64 63.46 PSI_12 | 1 0.64 64.10 PSI_14 | 1 0.64 64.74 PSI_15 | 1 0.64 65.38 PSI_4 | 1 0.64 66.03 PSI_6 | 1 0.64 66.67 PSI_90 | 1 0.64 67.31 PSI_90_HVBP_Baseline | 1 0.64 67.95 PSI_90_HVBP_Performance | 1 0.64 68.59 READM_30_AMI | 1 0.64 69.23 READM_30_AMI_HRRP | 1 0.64 69.87 READM_30_CABG | 1 0.64 70.51 READM_30_COPD | 1 0.64 71.15 READM_30_COPD_HRRP | 1 0.64 71.79 READM_30_HF | 1 0.64 72.44 READM_30_HF_HRRP | 1 0.64 73.08 READM_30_HIP_KNEE | 1 0.64 73.72 READM_30_HIP_KNEE_HRRP | 1 0.64 74.36 READM_30_HOSP_WIDE | 1 0.64 75.00 READM_30_PN | 1 0.64 75.64 READM_30_PN_HRRP | 1 0.64 76.28 READM_30_STK | 1 0.64 76.92 SCIP_Card_2 | 1 0.64 77.56 SCIP_Card_2_HVBP_Baseline | 1 0.64 78.21 SCIP_Card_2_HVBP_Performance | 1 0.64 78.85 SCIP_Inf_1 | 1 0.64 79.49 SCIP_Inf_2 | 1 0.64 80.13 SCIP_Inf_2_HVBP_Baseline | 1 0.64 80.77 SCIP_Inf_2_HVBP_Performance | 1 0.64 81.41 SCIP_Inf_3 | 1 0.64 82.05 SCIP_Inf_3_HVBP_Baseline | 1 0.64 82.69 SCIP_Inf_3_HVBP_Performance | 1 0.64 83.33 SCIP_Inf_9 | 1 0.64 83.97 SCIP_Inf_9_HVBP_Baseline | 1 0.64 84.62 SCIP_Inf_9_HVBP_Performance | 1 0.64 85.26 SCIP_VTE_2 | 1 0.64 85.90 SCIP_VTE_2_HVBP_Baseline | 1 0.64 86.54 SCIP_VTE_2_HVBP_Performance | 1 0.64 87.18 SM_5 | 1 0.64 87.82 SM_PART_CARD | 1 0.64 88.46 SM_PART_GEN_SURG | 1 0.64 89.10 SM_PART_NURSE | 1 0.64 89.74 STK_1 | 1 0.64 90.38 STK_10 | 1 0.64 91.03 STK_2 | 1 0.64 91.67 STK_3 | 1 0.64 92.31 STK_4 | 1 0.64 92.95 STK_5 | 1 0.64 93.59 STK_6 | 1 0.64 94.23 STK_8 | 1 0.64 94.87 SUB_1 | 1 0.64 95.51 Star Rating | 1 0.64 96.15 VTE_1 | 1 0.64 96.79 VTE_2 | 1 0.64 97.44 VTE_3 | 1 0.64 98.08 VTE_4 | 1 0.64 98.72 VTE_5 | 1 0.64 99.36 VTE_6 | 1 0.64 100.00 ----------------------------------------+----------------------------------- Total | 156 100.00 Frequencies for measureid variable in measure_dates dataset : Measure ID | Freq. Percent Cum. ----------------------------------------+----------------------------------- ACS_REGISTRY | 1 0.64 0.64 AMI_7a | 1 0.64 1.28 AMI_7a_HVBP_Baseline | 1 0.64 1.92 AMI_7a_HVBP_Performance | 1 0.64 2.56 AMI_8a | 1 0.64 3.21 CAC_3 | 1 0.64 3.85 COMP_HIP_KNEE | 1 0.64 4.49 Combined_SSI_Measure_Score | 1 0.64 5.13 Combined_SSI_Measure_Score_HVBP_Perfo.. | 1 0.64 5.77 EDV | 1 0.64 6.41 ED_1b | 1 0.64 7.05 ED_2b | 1 0.64 7.69 FUH_30 | 1 0.64 8.33 FUH_7 | 1 0.64 8.97 HACRP_CAUTI | 1 0.64 9.62 HACRP_CLABSI | 1 0.64 10.26 HACRP_D1 | 1 0.64 10.90 HACRP_D2 | 1 0.64 11.54 HACRP_PSI90 | 1 0.64 12.18 HACRP_SSI | 1 0.64 12.82 HACRP_Total | 1 0.64 13.46 HAI_1 | 1 0.64 14.10 HAI_1_HVBP_Baseline | 1 0.64 14.74 HAI_1_HVBP_Performance | 1 0.64 15.38 HAI_1a | 1 0.64 16.03 HAI_2 | 1 0.64 16.67 HAI_2_HVBP_Baseline | 1 0.64 17.31 HAI_2_HVBP_Performance | 1 0.64 17.95 HAI_2a | 1 0.64 18.59 HAI_3 | 1 0.64 19.23 HAI_3_HVBP_Baseline | 1 0.64 19.87 HAI_3_HVBP_Performance | 1 0.64 20.51 HAI_4 | 1 0.64 21.15 HAI_4_HVBP_Baseline | 1 0.64 21.79 HAI_4_HVBP_Performance | 1 0.64 22.44 HAI_5 | 1 0.64 23.08 HAI_6 | 1 0.64 23.72 HBIPS_2 | 1 0.64 24.36 HBIPS_3 | 1 0.64 25.00 HBIPS_4 | 1 0.64 25.64 HBIPS_5 | 1 0.64 26.28 HBIPS_6 | 1 0.64 26.92 HBIPS_7 | 1 0.64 27.56 HCAHPS | 1 0.64 28.21 HCAHPS_HVBP_Baseline | 1 0.64 28.85 HCAHPS_HVBP_Performance | 1 0.64 29.49 HF_2 | 1 0.64 30.13 IMM_2 | 1 0.64 30.77 IMM_2_HVBP_Baseline | 1 0.64 31.41 IMM_2_HVBP_Performance | 1 0.64 32.05 IMM_3_OP_27 | 1 0.64 32.69 IPFQR_EHR | 1 0.64 33.33 IPFQR_PEoC | 1 0.64 33.97 Linear Score | 1 0.64 34.62 MORT_30_AMI | 1 0.64 35.26 MORT_30_AMI_HVBP_Baseline | 1 0.64 35.90 MORT_30_AMI_HVBP_Performance | 1 0.64 36.54 MORT_30_CABG | 1 0.64 37.18 MORT_30_COPD | 1 0.64 37.82 MORT_30_HF | 1 0.64 38.46 MORT_30_HF_HVBP_Baseline | 1 0.64 39.10 MORT_30_HF_HVBP_Performance | 1 0.64 39.74 MORT_30_PN | 1 0.64 40.38 MORT_30_PN_HVBP_Baseline | 1 0.64 41.03 MORT_30_PN_HVBP_Performance | 1 0.64 41.67 MORT_30_STK | 1 0.64 42.31 MSPB_1 | 1 0.64 42.95 MSPB_1_HVBP_Baseline | 1 0.64 43.59 MSPB_1_HVBP_Performance | 1 0.64 44.23 OP_1 | 1 0.64 44.87 OP_10 | 1 0.64 45.51 OP_11 | 1 0.64 46.15 OP_12 | 1 0.64 46.79 OP_13 | 1 0.64 47.44 OP_14 | 1 0.64 48.08 OP_17 | 1 0.64 48.72 OP_18b | 1 0.64 49.36 OP_2 | 1 0.64 50.00 OP_20 | 1 0.64 50.64 OP_21 | 1 0.64 51.28 OP_22 | 1 0.64 51.92 OP_23 | 1 0.64 52.56 OP_25 | 1 0.64 53.21 OP_26 | 1 0.64 53.85 OP_3b | 1 0.64 54.49 OP_4 | 1 0.64 55.13 OP_5 | 1 0.64 55.77 OP_8 | 1 0.64 56.41 OP_9 | 1 0.64 57.05 PAYM_30_AMI | 1 0.64 57.69 PAYM_30_HF | 1 0.64 58.33 PAYM_30_PN | 1 0.64 58.97 PCH_1 | 1 0.64 59.62 PCH_2 | 1 0.64 60.26 PCH_3 | 1 0.64 60.90 PC_01 | 1 0.64 61.54 PN_6 | 1 0.64 62.18 PN_6_HVBP_Baseline | 1 0.64 62.82 PN_6_HVBP_Performance | 1 0.64 63.46 PSI_12 | 1 0.64 64.10 PSI_14 | 1 0.64 64.74 PSI_15 | 1 0.64 65.38 PSI_4 | 1 0.64 66.03 PSI_6 | 1 0.64 66.67 PSI_90 | 1 0.64 67.31 PSI_90_HVBP_Baseline | 1 0.64 67.95 PSI_90_HVBP_Performance | 1 0.64 68.59 READM_30_AMI | 1 0.64 69.23 READM_30_AMI_HRRP | 1 0.64 69.87 READM_30_CABG | 1 0.64 70.51 READM_30_COPD | 1 0.64 71.15 READM_30_COPD_HRRP | 1 0.64 71.79 READM_30_HF | 1 0.64 72.44 READM_30_HF_HRRP | 1 0.64 73.08 READM_30_HIP_KNEE | 1 0.64 73.72 READM_30_HIP_KNEE_HRRP | 1 0.64 74.36 READM_30_HOSP_WIDE | 1 0.64 75.00 READM_30_PN | 1 0.64 75.64 READM_30_PN_HRRP | 1 0.64 76.28 READM_30_STK | 1 0.64 76.92 SCIP_Card_2 | 1 0.64 77.56 SCIP_Card_2_HVBP_Baseline | 1 0.64 78.21 SCIP_Card_2_HVBP_Performance | 1 0.64 78.85 SCIP_Inf_1 | 1 0.64 79.49 SCIP_Inf_2 | 1 0.64 80.13 SCIP_Inf_2_HVBP_Baseline | 1 0.64 80.77 SCIP_Inf_2_HVBP_Performance | 1 0.64 81.41 SCIP_Inf_3 | 1 0.64 82.05 SCIP_Inf_3_HVBP_Baseline | 1 0.64 82.69 SCIP_Inf_3_HVBP_Performance | 1 0.64 83.33 SCIP_Inf_9 | 1 0.64 83.97 SCIP_Inf_9_HVBP_Baseline | 1 0.64 84.62 SCIP_Inf_9_HVBP_Performance | 1 0.64 85.26 SCIP_VTE_2 | 1 0.64 85.90 SCIP_VTE_2_HVBP_Baseline | 1 0.64 86.54 SCIP_VTE_2_HVBP_Performance | 1 0.64 87.18 SM_5 | 1 0.64 87.82 SM_PART_CARD | 1 0.64 88.46 SM_PART_GEN_SURG | 1 0.64 89.10 SM_PART_NURSE | 1 0.64 89.74 STK_1 | 1 0.64 90.38 STK_10 | 1 0.64 91.03 STK_2 | 1 0.64 91.67 STK_3 | 1 0.64 92.31 STK_4 | 1 0.64 92.95 STK_5 | 1 0.64 93.59 STK_6 | 1 0.64 94.23 STK_8 | 1 0.64 94.87 SUB_1 | 1 0.64 95.51 Star Rating | 1 0.64 96.15 VTE_1 | 1 0.64 96.79 VTE_2 | 1 0.64 97.44 VTE_3 | 1 0.64 98.08 VTE_4 | 1 0.64 98.72 VTE_5 | 1 0.64 99.36 VTE_6 | 1 0.64 100.00 ----------------------------------------+----------------------------------- Total | 156 100.00 by Jean Roth , jroth@nber.org , 15 Nov 2016